Re: END OF AN ERA AS BROOKHAVEN LAB CLOSES NUCLEAR REACTOR

["Sandy Perle" <sandyfl@earthlink.net>]

> the lab's director, John
> Marburger, said the "discouraging results" of recent clinical trials,
> along with a dwindling enthusiasm for this research among government
> agencies, convinced the lab that the reactor should be closed.

What a shame. Perhaps the flame burned out with all of the political 
upheaval. It's unheard of to hear a research facility state that they 
are closing the "test facility" or the "research" due to discouraging 
results. All research doesn't end up with a home run right out of the 
gate. Research takes time, and there will be ups and there will be 
downs as well. All part of the game.

While I visited Kyoto University, where they are performing brain 
surgery using their test reactor, it is gratifying that there is 
research still continuing in some part of the world. Too bad the USA 
will be relegated to a "has been" in an area where we used to be out 
in front. It's an embarrassment to see BNL shut down. Many should be 
ashamed of themselves.

------------------------------------------------------------------------
Sandy Perle					Tel:(714) 545-0100 / (800) 548-5100   				    	
Director, Technical				Extension 2306 				     	
ICN Worldwide Dosimetry Division		Fax:(714) 668-3149 	                   		    
ICN Biomedicals, Inc.				E-Mail: sandyfl@earthlink.net 				                           
ICN Plaza, 3300 Hyland Avenue  		E-Mail: sperle@icnpharm.com          	          
Costa Mesa, CA 92626                                      

Personal Website:  http://www.geocities.com/capecanaveral/1205
ICN Worldwide Dosimetry Website: http://www.dosimetry.com

************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html